Brought to you by 
Takeda, Molecular Templates collaborate in multi-target oncology drug discovery
24 Sep 2018
Executive Summary
Takeda Pharmaceutical Co. Ltd., through its Millennium Pharmaceuticals division (now known as Takeda Oncology), and Molecular Templates Inc. (MTI) have agreed to collaborate on multi-target drug discovery programs in oncology.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Takeda, Molecular Templates collaborate in multi-target oncology drug discovery
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice